MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$3,323,384
EPS
-$0.87
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
1,918,424
1,376,861
1,295,286*
922,857
General and administrative
1,743,817
1,715,639
1,946,495*
1,020,154
Total operating expenses
3,662,241
3,092,500
3,241,781
1,943,011
Loss from operations
-3,662,241
-3,092,500
-3,241,781*
-1,943,011
Other income (expense), net
338,857
83,449
49,335*
35,224
Change in fair value of warrant liability
0
-
-325*
-611
Total other income (expense), net
338,857
83,449
49,660*
35,835
Net loss
-3,323,384
-3,009,051
-3,192,121*
-1,907,176
Deemed dividends
0
5,681,616
-2,357,698*
2,769,742
Net loss attributable to common stockholders
-3,323,384
-8,690,667
-834,423
-4,676,918
Basic EPS
-0.87
-2.71
0.595
-1.77
Diluted EPS
-0.87
-2.71
0.595
-1.77
Basic Average Shares
3,829,363
3,207,720
-1,403,163
2,644,733
Diluted Average Shares
3,829,363
3,207,720
-1,403,163
2,644,733
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$3,323,384 Other income(expense), net$338,857 Net loss-$3,323,384 Total other income(expense), net$338,857 Loss from operations-$3,662,241 Total operatingexpenses$3,662,241 Research and development$1,918,424 General andadministrative$1,743,817

REVELATION BIOSCIENCES, INC. (REVB)

REVELATION BIOSCIENCES, INC. (REVB)